104 related articles for article (PubMed ID: 29212111)
1. Pathophysiological Mechanisms of Endogenous FVIII Release following Strenuous Exercise in Non-severe Haemophilia: A Review.
Venema CL; Schutgens REG; Fischer K
Thromb Haemost; 2017 Dec; 117(12):2237-2242. PubMed ID: 29212111
[TBL] [Abstract][Full Text] [Related]
2. Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A.
Shi Q; Fahs SA; Kuether EL; Cooley BC; Weiler H; Montgomery RR
Blood; 2010 Oct; 116(16):3049-57. PubMed ID: 20606161
[TBL] [Abstract][Full Text] [Related]
3. Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings.
Turner NA; Moake JL
PLoS One; 2015; 10(10):e0140740. PubMed ID: 26473492
[TBL] [Abstract][Full Text] [Related]
4. Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells.
van den Biggelaar M; Bouwens EA; Voorberg J; Mertens K
PLoS One; 2011; 6(8):e24163. PubMed ID: 21909383
[TBL] [Abstract][Full Text] [Related]
5. Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells.
van den Biggelaar M; Bouwens EA; Kootstra NA; Hebbel RP; Voorberg J; Mertens K
Haematologica; 2009 May; 94(5):670-8. PubMed ID: 19336741
[TBL] [Abstract][Full Text] [Related]
6. Protected by nature? Effects of strenuous physical exercise on FVIII activity in moderate and mild haemophilia A patients: a pilot study.
Groen WG; den Uijl IE; van der Net J; Grobbee DE; de Groot PG; Fischer K
Haemophilia; 2013 Jul; 19(4):519-23. PubMed ID: 23510308
[TBL] [Abstract][Full Text] [Related]
7. Impact of aerobic exercise on haemostatic indices in paediatric patients with haemophilia.
Kumar R; Bouskill V; Schneiderman JE; Pluthero FG; Kahr WH; Craik A; Clark D; Whitney K; Zhang C; Rand ML; Carcao M
Thromb Haemost; 2016 Jun; 115(6):1120-8. PubMed ID: 26917411
[TBL] [Abstract][Full Text] [Related]
8. Effects of moderate-intensity physical exercise on pharmacokinetics of factor VIII and von Willebrand factor in young adults with severe haemophilia A: a pilot study.
Zourikian N; Merlen C; Bonnefoy A; St-Louis J; Rivard GE
Haemophilia; 2016 May; 22(3):e177-83. PubMed ID: 26988074
[TBL] [Abstract][Full Text] [Related]
9. Genetic induction of a releasable pool of factor VIII in human endothelial cells.
Rosenberg JB; Greengard JS; Montgomery RR
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2689-95. PubMed ID: 11116073
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertension.
Shovlin CL; Angus G; Manning RA; Okoli GN; Govani FS; Elderfield K; Birdsey GM; Mollet IG; Laffan MA; Mauri FA
PLoS One; 2010 Feb; 5(2):e9154. PubMed ID: 20174619
[TBL] [Abstract][Full Text] [Related]
11. Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
Zollner S; Raquet E; Claar P; Müller-Cohrs J; Metzner HJ; Weimer T; Pragst I; Dickneite G; Schulte S
Thromb Res; 2014 Jul; 134(1):125-31. PubMed ID: 24814969
[TBL] [Abstract][Full Text] [Related]
12. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
Deitcher SR; Tuller J; Johnson JA
Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
[TBL] [Abstract][Full Text] [Related]
13. Factor VIII concentrate infusion in patients with haemophilia results in decreased von Willebrand factor and ADAMTS-13 activity.
van Bladel ER; Tuinenburg A; Roest M; de Groot PG; Schutgens RE
Haemophilia; 2014 Jan; 20(1):92-8. PubMed ID: 24028772
[TBL] [Abstract][Full Text] [Related]
14. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
Jones TR; Kao KJ; Pizzo SV; Bigner DD
Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
[TBL] [Abstract][Full Text] [Related]
16. Intracellular trafficking of factor VIII to von Willebrand factor storage granules.
Rosenberg JB; Foster PA; Kaufman RJ; Vokac EA; Moussalli M; Kroner PA; Montgomery RR
J Clin Invest; 1998 Feb; 101(3):613-24. PubMed ID: 9449695
[TBL] [Abstract][Full Text] [Related]
17. Interaction between VWF and FVIII in treating VWD.
Miesbach W; Berntorp E
Eur J Haematol; 2015 Nov; 95(5):449-54. PubMed ID: 25605439
[TBL] [Abstract][Full Text] [Related]
18. Regulated release of VWF and FVIII and the biologic implications.
Haberichter SL; Shi Q; Montgomery RR
Pediatr Blood Cancer; 2006 May; 46(5):547-53. PubMed ID: 16470522
[TBL] [Abstract][Full Text] [Related]
19. [Weibel-Palade bodies: unique secretory organelles within endothelial cells].
Romani de Wit T; Rondaij MG; van Mourik JA
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1572-7. PubMed ID: 15382555
[TBL] [Abstract][Full Text] [Related]
20. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J
Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
